IMMUNOBOOST - Bovine
Description

An immunotherapeutic injection for the treatment of E.coli (K99) diarrhea.
Please choose the country nearest you for more information.
Product Information for Egypt
INDICATIONS:
For use in calves, 1 to 5 days of age, as a one-time immunotherapeutic treatment for reduction of mortality and clinical signs associated with calf scours caused by E.coli (K99).
DOSAGE:
Using aseptic technique, inject one ml intravenously into calves one to five days of age, at the first sign of disease.
CAUTION:
Store at 2-7°C (35-45°F). Use entire contents when first opened. Contains Gentamcin as a preservative. Do not inoculate within 21 days of slaughter. In case of anaphylaxis, administer epinephrine.
PACKAGING:
5mL vials (5 doses)
20mL vials (20 doses)
Benefits of IMMUNOBOOST®:
Calves are born with a complete but immature immune system. IMMUNOBOOST® stimulates a calf's own immune system to enhance defense mechanisms against disease. Stimulating a non-specific immune response activates macrophages, interleukin production, and both cell mediated immunity and antibody production. "Turning on" the immune system helps a calf respond quickly and get back to normal health faster. A survival rate of 90% was demonstrated in an E.coli (K 99) challenge study with colostrum deprived calves treated once with IMMUNOBOOST®. No other supportive therapy was administered.
IMMUNOBOOST® is approved and licensed for use in bovine.
Single dose treatment is economical and labor saving.
IMMUNOBOOST® is classified as an immunostimulant. It will not lead to bacterial resistance like some antibiotics and antimicrobials. Tissue residue is not an issue with IMMUNOBOOST®.
Suppliers for Egypt
- Bioniche Animal Health (Europe) Ltd.
- Contact: Andrew Grant
- Kilroe East
- Invern , Co. Galway, Ireland
- Toll Free:
- Telephone: +353-9159-3202
- Fax: +353-9159-3228
- Order Desk Fax: +353-1-801-4100
* Note: This page will be printed in a printer friendly format.
Not all products are available in all countries, please contact us for further
information.